Unither | United Therapeutics Corporation



United Therapeutics has been an avid supporter of the Pulmonary Hypertension Association (PHA). The PHA works to raise awareness of PAH at both a national level, with activities such as the Physician/Allied Healthcare Professional Medical Education Seminars and International Patient Conferences, and at a local level through patient support groups or via fundraisers such as walk-a-thons or golf tournaments. We support all of these activities both financially and through the participation of our partners and employees. We were the first company to sponsor a $1 million endowment for the PHA and we are a charter member of the PHA's Corporate Committee, which is made up of other members of the pharmaceutical industry serving the PAH community. The Corporate Committee offers guidance to the PHA on various issues related to market dynamics as they affect patients with PAH, and drug access issues, among many other topics. In 2008, United Therapeutics received the prestigious PHA "Friends of the Family Award" in recognition of its continued support of the PHA and the patients it represents.


United Therapeutics has an active grants program to fund grants for research, scientific education or patient and charitable organizations. To inquire about our grants program or apply for a grant, please e-mail us at grants@unither.com.

United Therapeutics evaluates all grants in accordance with the criteria set forth in its Comprehensive Compliance Program. Submission of a grant request does not guarantee funding by United Therapeutics. If you are awarded funding, any amount paid or reimbursed related to your grant is not intended to be, nor shall it be construed as, an offer or payment made, whether directly or indirectly, to induce the referral of patients, the purchase or order of United Therapeutics' pharmaceutical products, the recommending or arranging for the purchase or order of United Therapeutics' pharmaceutical products, or an obligation, either express or implied, to prescribe or otherwise support United Therapeutics' pharmaceutical products.


United Therapeutics Corporation proudly sponsors the Hamilton Naki-MESAB-United Therapeutics Scholarship at the University of Cape Town (UCT). The scholarship was created in 2007 in order to provide a medical student with a full scholarship to attend medical school at UCT. United Therapeutics has pledged to fund an all-expense paid scholarship of $12,000 annually. We came to partner with UCT through the inspired work of Dr. Louis Sullivan, a member of our Board of Directors.

The Hamilton Naki-MESAB-United Therapeutics Scholarship is named in honor of Hamilton Naki. Naki has become a famous symbol of heart transplantation in South Africa. History places him as a close collaborator with Dr. Christian Barnard when he performed the first heart transplant at Groote Schuur Hospital in South Africa in 1967. Naki is recognized in many circles to have directly assisted Dr. Barnard as an integral part of the surgical team. In later years, he was widely honored and decorated for his roles as teacher, trainer and surgical assistant, even though he was overlooked during the apartheid years in South Africa. Naki was the recipient of the Order of Mapungubwe, South Africa's highest honor, in 2002 and was awarded an honorary Master of Science in Medicine by UCT in 2003. Naki died in 2005.